GoodRx shares are trading lower after the company issued Q3 total revenue guidance below estimates and cut the top end of FY23 total revenue guidance below estimates.
Portfolio Pulse from Benzinga Newsdesk
GoodRx has issued Q3 total revenue guidance below estimates and cut the top end of FY23 total revenue guidance below estimates, causing its shares to trade lower.
August 09, 2023 | 12:52 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GoodRx's shares are trading lower due to the company's lower than expected Q3 and FY23 revenue guidance.
GoodRx's lower than expected revenue guidance for Q3 and FY23 indicates potential financial underperformance, which is negatively impacting investor sentiment and causing the company's stock price to fall.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100